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ABSTRACT The pre-T-cell receptor, composed of the
T-cell receptor (TCR) j8 chain (TCRI8), pre-Tai (pTa) chain,
and CD3 molecules, has been postulated to be a transducer of
signals during the early stages of T-cell development. To
examine the function of the transmembrane pTa chain during
thymocyte development, we generated pTc-/- embryonic
stem cells and assayed their ability to differentiate into
lymphoid cells in vivo after injection into recombination-
activating gene (RAG)-2-deficient blastocysts. Thymocytes
representing all stages of T-cell differentiation were detected
in the thymus of pTa-/- chimeric mice, indicating that
thymocyte development can occur without pTa. However,
greatly reduced thymocyte numbers and substantially in-
creased percentages of both CD4-CD8- thymocytes and TCR
yB+ thymocytes suggest that pTa plays a critical role in
thymocyte expansion. To investigate the role of the pTa chain
in allelic exclusion at the TCR8 locus, a functionally rear-
ranged TCRI8 minigene was introduced into pTa-/- and
pTc+/- embryonic stem cells, which were subsequently as-
sayed by RAG-2-deficient blastocyst complementation. In the
absence of pTa, expression of the transgenic TCRf8 inhibited
rearrangement of the endogenous TCR0 locus to an extent
similar to that seen in normal TCRI3 transgenic mice, sug-
gesting that pTa may not be required for signaling allelic
exclusion at the TCR0 locus.
Lymphoid precursor cells progress into mature TCRaf3+ T
cells through successive stages characterized by expression of
distinct surface markers. These distinct developmental stages
include the immature CD4-CD8- [double-negative (DN)]
stage, CD4+CD8+ [double-positive (DP)] stage, and mature
CD4+ or CD8+ [single-positive (SP)] stage (1). Rearrange-
ment of the TCR/3 gene appears to be initiated at the DN stage
before the rearrangement and expression of TCRa gene (2, 3).
Accumulating evidence has suggested that the T-cell receptor
(TCR) ,B chain, in the absence of TCRa chain, is necessary and
sufficient to signal transition from DN to DP stage, as well as
expansion of thymocytes (4, 5). At these early stages, the
TCRj3 chain complexes with the transmembrane pre-T-cell
receptor a (pTa) chain and CD3 proteins to form the pre-TCR
(6-8). Therefore, the pre-TCR may be responsible for trans-
ducing signals essential for early thymocyte development.
Likewise, the pre-B-cell receptor, composed of membrane-
bound ,u heavy chain (im), surrogate light chain, Iga, and Igo3,
has been postulated to play critical roles during the early stages
of B-cell development (9). This hypothesis has been strongly
supported by the observations that targeted disruptions of the
i,Um and A5 components of the pre-B-cell receptor in mice
significantly impaired the transition from the pre-B-cell stage
to the mature B-cell stage and expansion of B-cell precursors
(10, 11).
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A single specificity of B and T cells is maintained through
allelic exclusion, which ensures that only one of the two alleles
potentially encoding immunoglobulin and TCR is expressed.
The phenomenon of allelic exclusion has been extensively
analyzed in transgenic mice. For B cells, high-level expression
of a functional membrane-bound (g-m), but not secreted ,.
heavy chain (p.s), inhibits V(D)J rearrangement at the endog-
enous IgH locus (12, 13), suggesting that the Utm may be
involved in allelic exclusion at the IgH locus. This hypothesis
was further supported by the finding that removal of the
membrane exon of the ltm chain not only blocks the transition
from pre-B cells to mature B cells but also abolishes allelic
exclusion at the IgH locus (14). Similarly, expression of a
functionally rearranged TCRf gene in transgenic mice inhibits
V(D)J rearrangement of the endogenous TCR3 locus (15),
suggesting that the TCR,B may play analogous roles in effecting
the allelic exclusion at the TCR3 locus. It has been proposed
that the ,Um may exert its effects on allelic exclusion through the
pre-B-cell receptor (9). In analogy, the TCRI3 chain may signal
allelic exclusion through the pre-TCR.
To investigate the function of the pTa gene and pre-TCR
during T-cell development, we generated pTa-/- embryonic
stem (ES) cells that were assayed by injection into recombi-
nation-activating gene (RAG)-2-deficient blastocysts after
which their progeny populate the lymphoid cell compartment
(16). In pTa-/- chimeric mice, T-lineage precursor cells could
complete the differentiation program into mature SP thymo-
cytes, but the thymocyte number was greatly reduced and the
percentages ofDN thymocytes and TCR Zy thymocytes were
greatly increased. These observations support the notion that
the pre-TCR plays an essential role in the expansion of DP
thymocytes. Furthermore, analysis ofTCRf3+pTa-/- chimeric
mice indicated that, as in TCR/ transgenic mice, the expres-
sion of the transgenic TCR,B also inhibited the V(D)J rear-
rangements of the endogenous TCR3 locus, suggesting that
disruption of the pTa chain does not interfere with allelic
exclusion at the TCR3 locus.
While this work was in progress, Fehling et al. reported that
disruption of the pTa gene in mice severely disrupted the
differentiation of TCR af3' T cells in the thymus (17). Our
findings on T-cell differentiation in pTa-/- chimeric mice
generally agree with those reported by Fehling et al.
MATERIAL AND METHODS
Cloning pTa cDNA. Full-length pTa cDNA was amplified by
PCR from a thymus cDNA library (Stratagene) using pTa-
specific primers (ref. 8; data not shown). The two-step PCR
reaction was done in a final 100-,ul vol containing 500 ng of
Abbreviations: TCR, T-cell receptor; pTa, pre-T-cell receptor a; DN,
double-negative; DP, double-positive; SP, single-positive; V(D)J, vari-
able-(diversity)-joining; ES, embryonic stem; RAG, recombination-
activating gene; PGK, phosphoglycerate kinase; ILm, membrane-bound
,t heavy chain; PE, phycoerythrin; FITC, fluorescein isothiocyanate.
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thymus cDNA, 300 ng of each primer, 1 x PCR buffer (Boeh-
ringer Mannheim), 0.2 mM dNTP, and 5 units of Taq poly-
merase (Boehringer Mannheim). The PCR reaction contained
26 cycles, each consisting of 1 min at 94°C and 2.5 min at 66°C.
The final reaction step was followed with an extension at 72°C
for 10 min.
The PCR product was cloned into the BamHI site of
pBluescript SK and verified by DNA sequencing. The pTa-
specific primers are as follows: 5'-TAGGGATCCTGGCTGC-
AACTGGGCTCATGCTTC-3'; 5'-CAGGGATCCGGGCT-
CAGACGGGTGGGTAAGATC-3'.
Construction of pTa Targeting Construct. The pTa cDNA
was used to screen a murine 129 genomic library (Stratagene).
Positive phage clones were plaque-purified as described (18).
Genomic DNA of pTa was extracted from the positive phage
clones as described and cloned into the Sal I-BamHI sites of
pBluescript SK (18). The exon-intron structure of pTa was
characterized by Southern blotting analysis and DNA sequenc-
ing. The targeting construct was designed to delete a 320-bp
exon that initiated at nt 178 and ended at nt 498 (numbering
is according to the pTa sequence deposited in GenBank,
accession number U16958) and was generated by replacing a
1.8-kb Nsi I-BamHI fragment containing the 320-bp exon with
the phosphoglycerate kinase promoter (PGK)-neomycin re-
sistance gene and subsequent insertion of the PGK-thymidine
kinase in one end of pTa genomic sequence (Fig. 1 A and B).
The 320-bp exon encodes most of the extracellular region of
pTa, including the immunoglobulin domain (8). Furthermore,
deletion of the exon will disrupt the reading frame of any
truncated pTa transcripts that can potentially be generated by
splicing from the exon 5' of the deleted exon to the exons 3'
of the deleted exon. Therefore, homologous recombination
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FiG. 1. Targeted disruption of the pTa gene. (A) Genomic con-
figuration of the pTa locus and design of pTa targeting construct. The
closed box represents the 320-bp coding exon of pTa, which was
replaced with PGK-neor in the targeting construct. The restriction sites
are as follows: B, BamHI; H, HindIII; R, EcoRI; N, Nsi I; Xb, Xba I;
X,Xho I. The probe is a 300- to 400-bp genomic fragment as indicated
above. (B) The genomic configuration of the pTa locus after homol-
ogous recombination with the targeting construct. (C) Southern blot
analysis of the targeted ES cells and the contribution of pTa-/- ES
cell to various tissues of pTa-/- chimeric mice. Ten micrograms of
genomic DNA was digested with BamHI and probed with the probe
indicated in Fig. 1A. Lanes: 1, normal ES cell; 2 and 3, pTa+/- ES cell
clones pH3.6 and pH4.2; 4 and 5, pTa-/- ES cell clones Tal6 and
Ta164; 6, thymocytes from control mouse; 7, thymocytes from pTa-/-
chimeric mouse; 8 and 9, lung and kidney of pTa-/- chimeric mice.
between the targeting construct and endogenous loci should
destroy the ability to produce pTa protein.
Generation of pTa+/- and pTa-/- ES Cells. Ji ES cells
were cultured and electroporated with the linearized targeting
construct as described (19). The transfected cells were selected
with G418 (300 ,ug/ml) and gancyclovior (2 ,uM) as described
(20). Homologous recombination events were screened by
Southern blotting analysis with BamHI digestion and hybrid-
ization to the probe shown in Fig. 1A. Autoradiography was
done with a phosphoimager (Molecular Dynamics). To gen-
erate pTa-/- ES cells, pTa+ - ES cells were cultured under
increased G418 concentrations as described (21). ES cells
surviving selection at G418 at 3.6 mg/ml were expanded and
screened with Southern blot analysis. Identified pTa-/- ES
cells were subcloned. The ES cells were injected into blasto-
cysts from RAG-2-/- mice, and progeny lymphoid cells were
analyzed (16).
Generation of TCRIB+pTa+/- and TCRS+pTa-/- ES
Cells. Approximately 40 ,ug of a TCR3 minilocus (22), which
expressed a functionally rearranged V,B8+ TCR,B chain, was
electroporated together with 5 ,tg of linearized plasmid con-
taining PGK-hygromycin resistance gene into pTac/- and
pTa-/- ES cells. The transfectants were selected with hygro-
mycin at 110 jig/ml, and surviving ES colonies were expanded
and screened by Southern blotting for the existence of the
TCRf transgene (data not shown). TCRP3+pTa+/- and
TCRP+pTa-/- ES cells that contained four copies of the
TCRf3 transgene were subcloned and assayed by RAG-2-
deficient blastocyst complementation.
Flow Cytometric Analysis. Single-cell suspensions from
spleen and thymus were prepared as described (23). Half a
million cells were stained with 1 ,ug of fluorescein (FL)-,
phycoerythrin (PE)-, or biotinylated monoclonal antibodies
for 30 min on ice. After being washed twice, biotin conjugates
were revealed by fluorescein isothiocyanate (FITC)-, PE-
conjugated streptavidin. Stained cells were analyzed with a
CELLQUEST program on a FACScan (fluorescense-activated
cell sorter; Becton Dickinson). Cells residing in the lympho-
cyte gate defined by light scatter were further analyzed (24).
FITC-conjugated-anti-Ly9.1, PE-conjugated-anti-B220, anti-
V,37, and biotinylated anti-IgM, anti-VP,8 were from Phar-
Mingen; FITC-conjugated anti-CD8, PE-conjugated anti-
CD4, anti-TCRac3, anti-TCRy6, and biotinylated anti-CD3,
were from Southern Biotechnology Associates.
Analysis of the Rearrangement of the Endogenous TCR8
Locus by Quantitative PCR Assay. Quantitative PCR assays
were designed to detect some DJ and V(D)J rearrangements
of the TCRf locus. Primers specific for VP 6,7, Df2, and Jf2.2
were used to detect rearrangements from VP36,7 to J,B2 and
Df32 to J,B2, respectively (see Fig. 3B). To control for the
amount ofDNA in each PCR reaction, primers specific for IgK
genomic DNA (around the CK region) were used to amplify a
0.9-kb genomic DNA fragment. For each thymocyte DNA
sample, sequentially diluted genomic DNA of 0.2, 0.05, and
0.02 g.g was supplemented with genomic DNA isolated from
ES cells to 0.2 ,ug and assayed with the PCR reactions. PCR
assays were done in a final 50-,ul vol containing 0.2 ,ug of
genomic DNA, lx PCR buffer (Boehringer Mannheim), 25
nM of each primer (V16,7 and J032 primers or D132 and Jf32
primers or IgK primers), 0.2 mM dNTP, and 2 units of Taq
polymerase (Boehringer Mannheim). The PCR reaction went
for 28 cycles, each consisting of 1 min at 94°C, 1.5 min at 60°C,
and 1.5 min at 72°C. The final reaction step was followed with
an extension at 72°C for 10 min. One-fifth of each reaction was
resolved on 1% agarose gel and assayed with Southern blotting
analysis, hybridizing to a probe covering Jf32.1 to J,32.2 (see
Fig. 3B). Autoradiography and analysis of the intensity of
autographic bands were done with a phosphoimager.
The primers used in these reactions were as follows: V,B6
primer, 5'-AATTCCTGATTGGTCAGGAA-3'; V,B7
I
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primer, 5'-CTGATCAAAAGAATGGGAGA-3'; Df32
primer, 5'-ATGAGAAAGGACTTGTAACTTCTTTC-
CCAC-3'; Jt32 primer, 5'-AATCCCAGGATCCAATC-
CAG-3'. Two IgK primers are as follows: 5'-AGGGTGACT-
TATTGGAGATTTCAGAAAT-3'; 5'-TCTCCTGTCTCT-
TCCAAGAATACTCTGA-3'.
RESULTS
Targeted Disruption of the pTa Gene in ES Cells. A
replacement targeting construct was generated and used to
replace a 320-bp exon of pTa with the PGK-neor gene (Fig. 1
A and B). To screen for homologous recombination events,
genomic DNA was digested with BamHI and probed with a
pTa genomic fragment that was not included in the targeting
construct, giving a 4.5-kb germ-line band or a 6.6-kb mutated
allele (Fig. 1 A and B). Of the ES clones screened, 25%
contained one mutant allele (two of the pTac/- ES clones,
pH3.6 and pH4.2, are shown in lanes 2 and 3 of Fig. 1C).
To generate pTa-/- ES cells, pH3.6 and pH4.2 ES cells
were grown under higher G418 concentrations. ES clones
surviving the selection of G418 at 3.6 mg/ml were expanded,
and their genomic DNA was analyzed (two of the pTa-/- ES
cells, Tal6 and TaI64, are shown in lanes 4 and 5 of Fig. 1C).
The Southern blot shown in Fig. 1C was stripped and probed
with the 320-bp exon. While a 9-kb band was seen in lanes that
contain DNA from the wild-type ES cell and pTa+/- ES cells,
no hybridization signal can be detected in lanes containing
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pTa-/- ES cell DNA (data not shown). This result confirmed
that the 320-bp exon had been deleted from the chromosome
of pTa-/- ES cells.
Lymphoid Differentiation in pTa-/- Chimeric Mice. The
pTa-/- ES cells and pTa+/+ control ES cells were separately
injected into RAG-2-deficient blastocysts, and lymphoid dif-
ferentiation was analyzed in 2- to 5-week-old chimeric mice. A
similar number of mature B cells were detected in the spleens
of pTa+/+ and pTa-/- chimeric mice, indicating that pTa was
not required for the development of B-lineage cells (Fig. 2B).
In the thymus of pTa-/- chimeric mice, the number of
thymocytes was -5- to 10-fold lower than that of normal mice
of the same age (Fig. 2E). However, immature CD4-CD8-,
CD4+CD8+ and mature CD4+CD8- or CD4-CD8+ thymo-
cytes were all present (Fig. 2A). Furthermore, while the
percentage of CD3+TCRaf3' thymocytes in pTa-/- chimeric
mice was similar to that of control, the percentage of
CD3+TCR ,yS thymocytes was increased >10-fold (Fig. 2D).
Also, while the DN thymocytes represented only 1-2% of
thymocytes in control mice, a much higher percentage of DN
thymocytes was present in the thymus of pTa-/- chimeric
mice (Fig. 2A).
Because the RAG-2-deficient blastocysts used to generate
pTa-/- chimeric mice were Ly9.2+, and ES cell-derived
lymphocytes are Ly9.1+, an anti-Ly-9.1 antibody was used to
distinguish the DN thymocytes derived from pTa-/- ES cells
and RAG-2-deficient blastocysts (25). When stained simulta-
neously for CD4 and Ly9.1 markers, thymocytes derived from
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spleen
IgM
D
F--
Ly9.1
Cx:
cr-
E
200
0
X$ 150
a)
-Q
E
71 i~oo
0 50
E
H-
pTae/+ pTa /
0-
El
03
10
B
E1
*. #
o wild type
* pTo-/-
CD3 1
FIG. 2. Flow cytometry analysis of lymphoid cells in pTa-/- chimeric mice. Thymocytes from pTa+/+ and pTa-/- chimeric mice were stained
with FITC-conjugated anti-CD8 and PE-conjugated anti-CD4 (A), PE-conjugated anti-CD4 and FITC-conjugated-anti-Ly9.1 (C) PE-conjugated
anti-TCRf3 and biotinylated anti-CD3 or PE-conjugated anti-TCR-y8 and biotinylated anti-CD3 (D). (B) Spleen cells from pTa+/- and pTa-/-
chimeric mice were stained with PE-conjugated anti-B220 and biotinylated anti-IgM. Biotin conjugates were revealed with streptavidin-FITC. Only
cells in the lymphocyte gate were analyzed. (E) The numbers of thymocytes derived from pTa-/- chimeric mice are represented as filled diamonds;
wild-type mice are indicated as squares.
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RAG-2-deficient blastocysts were Ly9.1-CD4-; thymocytes
from pTac/+ chimeric mice were predominantly Ly9.Ubright,
representing ES cell-derived DP and SP thymocytes; pTa-/-
chimeric mouse contained 24% of thymocytes that were
CD4-Ly9.1dull, while a background level of <1% thymocytes
were CD4-Ly-9.1-, representing DN thymocytes derived from
RAG-/- blastocysts (Fig. 2C). These CD4-Ly9.1dull thymo-
cytes represent ES-cell-derived DN thymocytes because other
CD4- cells, including the ES-cell-derived CD4-CD8+ SP
thymocytes and TCRy8+ thymocytes, were CD4-Ly9.1bright
(Fig. 2C; data not shown). In support of this conclusion,
Southern blot analysis of the contribution of pTc-/- ES cell
to different tissues of the pTa-/- chimeric mice revealed that
the thymocytes were predominantly derived from pTc-/- ES
cells, because in the thymocyte DNA the intensity of the
germ-line band of pTa was <5% that of the pTa mutant band
(Fig. 1C, lane 7). In conclusion, the majority ofDN thymocytes
in pTa-/- chimeric mice was derived from ES cells.
Allelic Exclusion. A productively rearranged TCR3 chain
was integrated into the genome of ES cells to generate
TCRI3+pTa+/- and TCR93+pTa-/- ES cells, both of which
were assayed by RAG-2-deficient blastocyst complementa-
tion. Because the transgene encodes a V,38+ TCR,3 chain,
thymocytes from TCRl3+pTac/- and TCRP3'pTa-/- chi-
meric mice were stained simultaneously with anti-CD3 and
anti-V,38 antibodies for expression of the transgene. In normal
mice, only 3% of TCR+ thymocytes were V,B8+ TCRhi;
however, essentially all TCRhi ag3' thymocytes were V,B8+ in
TCRl3+pTa+/- and TCROlpTa-/- chimeric mice (Fig. 3A).
Therefore, the TCR3 transgene was expressed in most thymo-
cytes of both TCRI3+pTac/- and TCRI3+pTa-/- chimeric mice.
About 4% of thymocytes were TCRy6' in TCRf3+pTc-/-
chimeric mice, probably explaining the few CD3+V,8- cells (Fig.
3A; data not shown). To analyze the expression of endogenous
TCR,3 chain in TCRI3+pTa+/- and TCR,3+pTa-/- chimeric
mice, thymocytes were simultaneously stained with anti-Vf37 and
anti-V,B8. While 3% thymocytes from normal mouse were V,B7+,
no V,B7+ thymocytes were present in TCR13+pTa+/- or
TCRf3+pTa-/- chimeric mice, suggesting that endogenous
TCR3 genes were not expressed (data not shown).
Although the lack of V/7 expression suggested that allelic
exclusion was operating in the pTc-/- chimeric mice, we also
used an assay of DNA rearrangement to examine this issue. In
TCR3 transgenic mice, the V(D)J rearrangements of the
endogenous TCR3 locus are suppressed. If pTa is essential for
allelic exclusion at the TCRI locus, there should be extensive
V(D)J rearrangements at the endogenous TCRj loci in
TCRf3+pTa-/- chimeric mice. To analyze the effect of ex-
pression of the TCR,3 chains on V(D)J rearrangement of
endogenous TCRf3 locus, a quantitative PCR assay was de-
signed to detect endogenous Vf36/7 to J,B2 or Df2 to Jf32
rearrangements (Fig. 3B). It was used to analyze genomic DNA
isolated from thymocytes of normal mice, TCR3 transgenic
mice, and Ly-9.1+ thymocytes of TCR/3+pTa+/- and
TCRf3+pTa-/- chimeric mice. Thymocyte DNA isolated from
two TCR13+pTa+/- chimeric mice and three TCRf3+pTa-/-
chimeric mice were analyzed. The level of Df32 to J,B2 rear-
rangement in the thymocyte DNA derived from TCR3 trans-
genic mice was similar to that in the DNA from
TCRf3+pTa+/- and TCRP3+pTa-/- chimeric mice but higher
than that of normal mice (Fig. 3C). However, as in TCR3
transgenic mice, the level of Vf37 to Jf32 rearrangement in the
thymocytes of TCRf3+pTa+/- and TCR,B+pTa-/- chimeric
mice was only -10% or less that in normal mice (Fig. 3C).
Similar results were obtained for the V,B6 to J32 rearrange-
ments (data not shown). Assuming that V,36/7(D)J,B2 rear-
rangements are representative of the overall status of the
TCR/3 loci, V to DJ rearrangements of the endogenous TCRf3
locus appear to be inhibited to the same extent in the thymo-
cytes of TCR/3'pTac/- and TCR(3+pTa-/- chimeric mice.
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FIG. 3. Expression of the transgenic TCR,B gene inhibits the V(D)J
rearrangements of the endogenous TCR,B genes in the thymocytes of
TCRf3+pTac/- and TCRP3+pTa-/- chimeric mice. (A) Expression of
VI38+ transgene in TCRl3+pTa+/- and TCRf+pTa-/- chimeric
mice. Thymocytes were stained with FITC-conjugated anti-CD3 and
biotinylated anti-V,B8. Biotin derivatives were revealed with PE-
conjugated streptavidin. (B) A schematic of the quantitative PCR
assay for V,B6/7 to J,B2 rearrangements. The location of specific
primers are indicated by arrowheads. The probe covering the J132.1 to
Jf32.2 region is also indicated. (C) Serially diluted genomic DNA
isolated from thymocytes of normal mice and TCRO3 transgenic mice
(22) as well as from Ly9.1+ thymocytes of TCRf3+pTa+/- and
TCR,3+pTa-/- chimeric mice were assayed for V,37 to J,B2 and D032
to J,B2 rearrangements by the PCR assay. As a control for the amount
ofDNA in each reaction, primers specific for IgK genomic region were
used to amplify a 0.9-kb DNA fragment from the same set of DNA
samples. Southern blots of the PCR reaction products hybridized with
the Jf32 probe and the 0.9 kb IgK probe are shown. The expected
amplification products are indicated with arrowheads.
DISCUSSION
The pTa gene is expressed predominantly during the early
stages of thymocyte development, and its product forms a
receptor complex with TCRf3 and CD3 molecules on the
surface of pre-T cells before expression of the TCRa chain (8).
On the basis of the dramatic decrease of thymocytes in
TCR3-/- mice but not in TCRa-/- mice, and the ability of a
functional TCR/ transgene in RAG-2-/- mice to restore the
number of thymocytes to a normal level, it has been suggested
that the pre-TCR transduces signals that lead to the expansion
of immature thymocytes (4, 5). Consistent with this hypothesis,
our work and a recent report by Fehling et al. (17) show that
disruption of the pTa gene also leads to a dramatic reduction
of the number of thymocytes in mice (17). This result dem-
iq
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onstrates directly that the pTa chain is functionally essential
for T-cell development. In this context, it may be relevant that
the pTa chain has an unusually long cytoplasmic tail compared
with that of the TCRa chain, suggesting that the cytoplasmic
tail of the pTa chain may be directly involved in a signal-
transduction process. However, because CD3 proteins have
been shown to transduce signals that lead to the transition from
the DN stage to the DP stage and the expansion of thymocytes
(26, 27), the intrinsic ability of pTa to transduce signals must
be addressed in the future.
The An, protein complexes with A5, Vpre B proteins, and
Iga/0 to form the pre-B-cell receptor complex (9). Targeted
disruption of the A5 gene led to an impairment of the pre-B to
mature B-cell transition and a diminished precursor B-cell
pool (10). Similarly, disruption of the pTa gene leads to a
reduced number of immature DP thymocytes in the pTa-/-
chimeric mice, although immature thymocytes can differenti-
ate into mature SP thymocytes. While a higher percentage than
normal of thymocytes in pTa-/- chimeric mice was DN, the
absolute number of DN thymocytes in pTa-/- chimeric mice
remained similar to that of normal mice. Therefore, the higher
percentage of DN thymocytes in pTa-/- chimeric mice is
likely due to the defective expansion of TCRac3+ DP thymo-
cytes.
Consistent with the recent report by Fehling et al. (17),
disruption of the pTa chain does not seem to affect the
development of TCRy6+ lineage T cells. It was only due to a
reduced number of DP thymocytes in pTa-/- chimeric mice
that the percentage of the TCR-y8+ thymocytes in the thymus
of pTa-/- chimeric mice was increased relative to that of
normal mice.
The expression of p.m has been implicated in the control of
allelic exclusion at the IgH locus (12-14), leading to the notion
that the pre-B-cell receptor signals allelic exclusion at the IgH
locus. In TCRj transgenic mice, expression of the transgenic
TCR3 chain inhibits the V to DJ rearrangement of the
endogenous TCRj loci, suggesting a role of the TCR3 chain,
and by extension, the pre-TCR in the allelic exclusion of the
TCR3 locus. However, in pTa-/- thymocytes, expression of a
functional TCRf3 chain inhibited the V to DJ rearrangements
of the endogenous TCR3 genes to the same extent as in TCR/3
transgenic mice. Therefore, the lack of pTa does not seem to
affect allelic exclusion at the TCRJ locus. Because TCRa chain
is rearranged and expressed in pTa-/- chimeric mice, we were
unable to determine whether TCRf3 chain could complex with
other proteins on the surface of the immature pTa-/- thy-
mocytes in the absence of TCRa chain. However, assuming
that no other gene products can compensate for the loss of
pTa, it appears that the pre-TCR may not be involved in the
signaling of allelic exclusion at TCR3 locus.
On the basis of recent findings that pre-TCR mediates rapid
clonal expansion of early thymocytes and RAG-2 protein is
degraded through phosphorylation by CDC2 before entry into
S phase (28, 29), it has been postulated that allelic exclusion at
the TCR3 locus could be achieved if RAG-2 is not fully
reactivated until the accessibility of the TCRf locus for
rearrangement is switched off and accessibility of the TCRa
locus is switched on. If this hypothesis is true, allelic exclusion
would be a by-product of cell-cycle regulation during early
thymocyte expansion (29). Our data argue against this hypoth-
esis because defective expansion of the immature thymocytes
in pTa-/- chimeric mice does not appear to affect allelic
exclusion.
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